To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Nicotinamide adenine dinucleotide (NAD+)

Musculoskeletal disease

INDICATION: Muscular dystrophy

Cell and mouse studies suggest promoting NAD+ synthesis could help

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE